Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.3%

7 terminated out of 62 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

11%

7 trials in Phase 3/4

Results Transparency

25%

7 of 28 completed with results

Key Signals

7 with results80% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (33)
Early P 1 (1)
P 1 (4)
P 2 (9)
P 3 (7)

Trial Status

Completed28
Recruiting10
Unknown7
Terminated7
Active Not Recruiting3
Withdrawn3

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 28 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT07086638Not ApplicableRecruitingPrimary

ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer

NCT07081074Not ApplicableRecruitingPrimary

ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

NCT06441266Not ApplicableRecruitingPrimary

M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

NCT05269160Phase 1TerminatedPrimary

Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)

NCT07400016Not ApplicableNot Yet RecruitingPrimary

Efficacy of Superoxide Dismutase Spray in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .

NCT07399990Not ApplicableNot Yet RecruitingPrimary

Efficacy of Superoxide Dismutase in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .

NCT04992650Not ApplicableEnrolling By Invitation

Ultrasonic Perfusion Imaging in Post-mastectomy Irradiated Patients

NCT02839473Phase 3Completed

Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial

NCT07149506Phase 3Enrolling By Invitation

Oral or Topical Catechins for Radiation Dermatitis

NCT07064577Not ApplicableRecruitingPrimary

Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

NCT07066280Phase 3Recruiting

Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer

NCT02384434Not ApplicableCompletedPrimary

Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma

NCT06484166Not ApplicableCompletedPrimary

Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .

NCT04166799Not ApplicableActive Not Recruiting

Randomized Phase III Trial With Mepitel Film for the Prophylaxis of Radiation Dermatitis in Breast Cancer Patients

NCT05594498Not ApplicableActive Not Recruiting

A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients

NCT06865131Not ApplicableActive Not Recruiting

Efficacy Study With StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breast Radiation Treatment in Large Breasted Women Using a Prone Technique

NCT06915857Phase 3Recruiting

Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position

NCT04173247Not ApplicableCompleted

Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy

NCT04110977Not ApplicableTerminatedPrimary

A Reminder App to Reduce Radiation Dermatitis Rates in Patients with Head-and-Neck Cancer

NCT06729814Recruiting

Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fractions Radiation Therapy

Scroll to load more

Research Network

Activity Timeline